QuidelOrtho Corporation (QDEL) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $17.49. It has a SharesGrow Score of 43/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of QDEL = $0.94 (-94.6% from the current price, the stock appears overvalued). Analyst consensus target is QDEL = $30 (+71.5% upside).
Valuation: QDEL trades at a trailing Price-to-Earnings (P/E) of -0.9 (S&P 500 average ~25).
Financials: revenue is $2.7B, -5.8%/yr average growth. Net income is $1.1B (loss), growing at -6757.9%/yr. Net profit margin is -41.5% (negative). Gross margin is 46.7% (-12.6 pp trend).
Balance sheet: total debt is $2.8B against $1.9B equity (Debt-to-Equity (D/E) ratio 1.46, moderate). Current ratio is 1.5 (strong liquidity). Debt-to-assets is 48.6%. Total assets: $5.8B.
Analyst outlook: 7 / 15 analysts rate QDEL as buy (47%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 25/100 (Fail), Health 50/100 (Partial), Moat 52/100 (Partial), Future 52/100 (Partial), Income 10/100 (Fail).
